Economical diagnostic system for accurate and rapid diagnosis and prevention of rare incurable diseases such as cancer and degenerative brain diseases
- · Started to apply the disease marker analysis technology, which is a proprietary technology owned by GlycoMetrix in the US.
- · Based on the proprietary technology, established a fast and accurate early cancer diagnosis system and DB Signature for the first time in the world
- · Early diagnosis system for various cancers including ovarian cancer, breast cancer, and pancreatic cancer
- · Currently researching and developing early diagnosis techniques for major degenerative brain diseases (e.g. Parkinson’s disease, and Alzheimer’s)
